MicroAlgo

MicroAlgo opened regular session weak at $3.82 and recovered modestly to close at $3.85, down 2.78% from the prior close, remaining 72% below its 52-week high of $13.6 and trading below both its 20-day MA ($4.1) and 60-day MA ($4.17). Pre-market activity ranged from $3.93 to $4.07, and the intraday high reached $3.96, but failed to reclaim the previous close, indicating lack of upward conviction. Q2 revenue fell 23% YoY to $10.06 million, net loss widened over 10x to $17.3 million, with EPS at -$1.39, reinforcing the fundamental weakness. Recent news on quantum encryption and reconfigurable simulation algorithm development failed to attract buyers, while the stock oscillated in a narrow range on thin volume.

MicroAlgo traded higher in regular session, surging 9.19% from prior close of $3.81 to $4.16 as of ET 10:31, driven by pre-market news of a reconfigurable quantum simulation technology development (see company press release). The stock rebounded from an intraday low of $3.81 to a high of $4.219, though volume was thin at 6,432 shares. Financially, Q2 revenue fell 23.28% YoY to $10.06M, net loss widened 1036.66% YoY to $17.28M, with EPS of -$1.3898. PE stood at -2.44, PB at 0.17. The stock remains 69.41% below its 52-week high of $13.6, but trades above its MA20 ($4.131) and near MA60 ($4.236); YTD it is down 18.75%. However, post-market trading slipped to $3.90, suggesting profit-taking.

MicroAlgo Inc. initially surged to $4.86 in pre-market trading before retreating, ultimately closing 3.68% higher at $4.23 during the regular session, driven by positive intraday news. The company recently announced a series of breakthroughs in quantum computing and encryption technologies, including reconfigurable simulation for quantum algorithms, quantum encryption based on lattice cryptography, and quantum architecture search (QAS) technology, aligning with rising market interest in AI and quantum computing at the edge. For full-year 2025, net profit surged 143.5% to approximately $12.49 million, while EPS soared 528.51% to $0.4981, though operating revenue slightly declined 2.78% to $16.72 million and operating income remained negative. The stock at $4.23 remains 68.9% below its 52-week high of $13.60 and has lost 17.38% YTD, trading below the 60-day MA of $4.53 but above the 20-day MA of $4.101, suggesting tentative short-term stabilization.

MicroAlgo (MLGO.US) weakened during the regular session, dragged by macro headwinds on micro-cap stocks and Nasdaq compliance concerns, alongside a slight YoY revenue decline. The stock slid from pre-market $4.13 to an intraday low of $3.95, closing at $3.95, down 5.3%. While full-year 2025 net profit surged 143.5% to ~$6.25M, with EPS of $0.4981 soaring 528.51% YoY and net margin at 37.4%, operating revenue edged down 2.78% to $16.72M, underscoring cost-control-driven profitability rather than top-line growth. At $3.95, the stock trades 70.96% below its 52-week high of $13.6, and sits below both the 20-day MA of $4.078 and 60-day MA of $4.531, with a YTD decline of 22.85%. However, after-hours trading saw a rebound to $4.106, suggesting some dip-buying interest.

MLGO.US rallied 5.20% during regular trading to $4.150, driven by pre-market announcements of reconfigurable quantum simulation technology and quantum encryption R&D progress, lifting investor sentiment. The stock opened at $3.960, climbed steadily through the $4.00 mark, and hit an intraday high of $4.150, albeit on thin volume of 8,275 shares. Full-year 2025 net profit surged 143.5% YoY, with Q4 net profit up 308.27% to $6.249 million, and net margin at 37.4%, though operating income remained negative, indicating cost controls improved but core operations are not yet profitable. The stock is still 69.5% below its 52-week high of $13.6, trades below the 60-day MA of $4.54, but has reclaimed the 20-day MA of $4.091. After-hours trading saw a pullback to $3.870, suggesting near-term momentum may be fragile.